South Korea Active Pharmaceutical Ingredients Market 规模与份额分析 - 成长趋势与预测 (2024 - 2031)
South Korea Active Pharmaceutical Ingredients Market is Segmented By Product Type (Low Potent APIs, High Potent APIs), By Molecular Type (Small Molecules, Large Molecules), By Formulation (Oral, Topical, Injectables, Drops), By Application (Diabetes, Oncology, Cardiovascular, CNS, Analgesics, Ophthalmic, Respiratory, Dermatology, Others). The report offers the value (in USD Billion) for the above-mentioned segments
South Korea Active Pharmaceutical Ingredients Market Size
市场规模（美元） Bn
复合年增长率5.1%
| 研究期 | 2024 - 2031 |
| 基准年 | 2023 |
| 复合年增长率 | 5.1% |
| 市场集中度 | Medium |
| 主要玩家 | 泰瓦制药公司 实业有限公司., 庆波药, 萨摩亚 药业股份有限公司., (原始内容存档于2019-09-26). SHINPOONG.CO, LTD, 库克坚制药有限公司. and Among Others. |
*免责声明：主要玩家未按特定顺序列出。
*来源：Coherent Market Insights
Want to purchase customized report?
please let us know !
please let us know !
South Korea Active Pharmaceutical Ingredients Market Analysis
韩国积极制药市场估计价值为: 2024年6.1 Bn美元 预计将达到 2031年之前为7.9 Bn美元,生长在一个 从2024年到2031年,CAGR为5.1%.
市场增长的动力是该国慢性病发病率的上升和老年人口的上升。